ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Oncolytics Biotech, Roche, AIO Initiate Gastrointestinal Cancer Trial americanpharmaceuticalreview
November 05, 2020Oncolytics Biotech? announced a new multi-indication gastrointestinal (GI) cancer study to be managed by AIO. The phase 1/2 trial, known as GOBLET, will investigate the use of pelareorep, in combination with Roche's anti-PD-L1 checkpoint inhibitor ...
Pharma Sources Insight January 2025
